Clinical Trial

Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial aims to compare the efficacy and safety of high-velocity nasal insufflation (HVNI) versus standard noninvasive ventilation (NIV) in adult patients experiencing acute exacerbations of community-acquired pneumonia (CAP) accompanied by hypoxemic respiratory failure. The primary focus is on assessing treatment failure within 48 hours, defined as the need for intubation or death. Secondary outcomes include evaluations of gas exchange parameters, patient comfort levels, duration of ICU stay, and 28-day mortality rates.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-21.
Status change: Not Yet Recruiting → Recruiting 2026-04-26
Trial Details
NCT Number NCT06996834
Lead Sponsor Assiut University
Conditions Community-acquired Pneumonia, Community-Acquired Infections
Enrollment 100 participants
Start Date 2025-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-30